New analysis has suggested the U.S. CBD market will be worth $3bn by 2023.
New CBD-Intel modelling has predicted a sharp increase in its CBD market value over the next two years, with massive growth stemming from anticipated regulatory changes.
CBD-intel predicts US Food and Drug Administration (FDA) rules providing a federal path to market are only likely to be developed later this year at the earliest, with a subsequent delay in market value realisation. As a result, food, drink and supplement products such as CBD oils, capsules and edibles will likely be hampered before fully coming into their own in 2023. However, they forecast that as that happens, the market will also witness a transition within food and supplement CBD product categories – switching from dominance by oil products to a capsule-led market.
This change will be spurred by ease of use and accurate dosing becoming more important as CBD is established as a standard health and wellness product. CBD-Intel believes capsules, with their standard dosing, instruction-free use and inoffensive profile, will overtake cumbersome and potentially unpleasant oils as the most popular product category with CBD consumers in the US and other markets.
Nate Erskine, CBD-Intel Head Market Analyst, commented: “Expect the rise of capsules and the continued success of the cosmetics and topicals categories to be the dominant market overview headlines for the next few years. Continued pressure on edibles, coupled with growing interest from sports and beauty applications, will help to fuel the continued rise of topicals as well as cosmetics, while companies will start to embrace capsules more and more as they seek to attract more of the hump of never-use CBD consumers to try products for the first time.
“Continued ease of use, combined with attractive pricing, will help convert those first-timers into regular users – though those who take CBD on a daily basis for health and wellness benefits may only move around within the capsule category and not move to try other product types.”
Read our latest issue
Latest News
Pharmacist Support launches 2024 ACTNow Campaign: tackling workplace culture, loneliness, and physical health across pharmacy teams
NATRUE Launches Natural Cosmetics Week 2024: ‘Embrace Nature, Empower Your Skin’
His Majesty The King becomes new Patron of RPS
New report highlights collaboration to enhance workforce wellbeing
Latest Tweets